UBS MSCI Swiss Dividend ETF CHF acc

What this fund is

UBS MSCI Swiss Dividend ETF CHF acc is an exchange-traded fund (ETF) from UBS, traded under the ticker CHDIVA (ISIN CH1416135353). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. In plain terms it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't, focused on the European market. It passively tracks the MSCI Swiss Dividend index — mirroring that market instead of paying a manager to pick winners, which keeps costs low, and its largest holdings include NOVARTIS AG-REG, ZURICH INSURANCE GROUP AG and NESTLE SA-REG. By geography it is weighted towards ~95.7% Switzerland.

Its heaviest sectors are ~39.1% Financials and ~29.7% Health Care. It is commonly used to tilt a portfolio towards one market, usually alongside broader, more global funds rather than on its own. Its ongoing charge (TER) is 0.12% a year — about €12 a year on a €10,000 holding, taken automatically from the fund. Income such as dividends is automatically reinvested inside the fund (an accumulating share class), so returns compound without you doing anything. It holds the underlying investments directly (physical replication); it is domiciled in Switzerland and trades in CHF.

Its price has swung about 12.4% over the past year — a gauge of how much the value moves, not a judgement of quality. It launched in 2025. As with any investment, its value can go down as well as up, and past performance is not a guide to future results. (Fund data sourced from UBS.)